Bristol Myers Squibb Net Common Equity Issued/Repurchased 2010-2025 | BMY
Bristol Myers Squibb net common equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.293B, a 97.47% decline year-over-year.
- Bristol Myers Squibb annual net common equity issued/repurchased for 2024 was $0B, a 100% decline from 2023.
- Bristol Myers Squibb annual net common equity issued/repurchased for 2023 was $-5.155B, a 35.57% decline from 2022.
- Bristol Myers Squibb annual net common equity issued/repurchased for 2022 was $-8.001B, a 27.26% increase from 2021.